BiVictriX Therapeutics
Stock Forecast, Prediction & Price Target

BiVictriX Therapeutics Financial Estimates

BiVictriX Therapeutics Revenue Estimates

BiVictriX Therapeutics EBITDA Estimates

BiVictriX Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
£0
 
N/A
£0
 
0%
£0
 
0%
Avg: £10M
Low: £10M
High: £10M
avg. 0%
Avg: £25M
Low: £25M
High: £25M
avg. 150%
Net Income
 
% change YoY
£-2.33M
 
N/A
£-2.49M
 
-6.75%
£-2.54M
 
-1.92%
Avg: £3.18M
Low: £3.18M
High: £3.18M
avg. 225.30%
Avg: £19.02M
Low: £19.02M
High: £19.02M
avg. 496.58%
EBITDA
 
% change YoY
£-1.45M
 
N/A
£-2.82M
 
-93.95%
£-2.86M
 
-1.27%
Avg: £0
Low: £0
High: £0
avg. 100%
Avg: £0
Low: £0
High: £0
avg. 0%
EPS
 
% change YoY
-$0.04
 
N/A
-$0.04
 
-6.77%
-$0.04
 
7.40%
Avg: $0.04
Low: $0.04
High: $0.04
avg. 225.42%
Avg: $0.26
Low: $0.26
High: $0.26
avg. 496.58%
Operating Expenses
 
% change YoY
£1.50M
 
N/A
£2.97M
 
98.06%
£2.86M
 
-3.86%
Avg: £0
Low: £0
High: £0
avg. -100%
Avg: £0
Low: £0
High: £0
avg. 0%

FAQ

What is BiVictriX Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 360.94% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is 3.18M, average is 3.18M and high is 3.18M.

What is BiVictriX Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 75% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is £10M, average is £10M and high is £10M.

What is BiVictriX Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 361.00% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is $0.04, average is $0.04 and high is £0.04.